Testing effectiveness (Phase 2)Not Yet RecruitingNCT07392229
What this trial is testing
Zanubritnib and Anti-MAG Neuropathy
Who this might be right for
Anti-MAG IgM-associated Demyelinating Polyneuropathy
Azienda Ospedaliera di Padova 50
Showing 2 of 2 results